<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03561948</url>
  </required_header>
  <id_info>
    <org_study_id>13</org_study_id>
    <nct_id>NCT03561948</nct_id>
  </id_info>
  <brief_title>Feasibility of Intraperitoneal Chemotherapy in the Surgical Treatment of Colon Cancer pT4</brief_title>
  <official_title>Feasibility of Intraperitoneal Chemotherapy in the Surgical Treatment of Colon Cancer pT4</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State Scientific Centre of Coloproctology, Russian Federation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State Scientific Centre of Coloproctology, Russian Federation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomised controlled study aims to determine the oncological effectiveness of
      adjuvant HIPEC, using intraperitoneal Mytomicin C following a curative resection of a T4
      Colon cancer in preventing the development of peritoneal carcinomatosis in addition to the
      standard adjuvant systemic treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the experimental group (60 patients) after laparotomy and revision of the abdominal cavity
      organs, peritoneal lavage will be performed followed by immunological examination. After
      performing the surgical intervention, the patient will undergo intraoperative intra-abdominal
      chemotherapy with mitomycin C. Further, lavage of the abdominal cavity will be repeated,
      followed by immunological examination.

      In the control group (60 patients), after laparotomy and revision, peritoneal lavage will
      also be performed, followed by immunological examination. Patients of this group will not
      receive intraoperative intra-abdominal chemotherapy. After performing the surgical
      intervention, the patient will perform irrigation of the abdominal cavity with physiological
      saline. Further, lavage of the abdominal cavity will be repeated, followed by immunological
      examination.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 9, 2018</start_date>
  <completion_date type="Anticipated">August 3, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 25, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Positive peritoneal lavage</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Cancer cell vitality</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Colon Cancer</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgery and Intraperitoneal Chemotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>only surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Experimental group</intervention_name>
    <description>After performing the surgical intervention, the patient will undergo intraoperative intra-abdominal chemotherapy with mitomycin C. Further, lavage of the abdominal cavity will be repeated, followed by immunological examination.</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control group</intervention_name>
    <description>In the control group (60 patients), after laparotomy and revision, peritoneal lavage will also be performed with subsequent immunological examination. Patients of this group will not receive intraperitoneal chemotherapy. After performing the surgical intervention, the patient will be irrigation of the abdominal cavity with physiological saline. Further, lavage of the abdominal cavity will be repeated, followed by immunological examination.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Colon cancer which represent cT4N0-2 M0 on the basis of preoperative examination data
             (CT of the chest, abdominal and pelvic organs) in line with The American Joint
             Committee on Cancer: the 7th edition of the AJCC cancer staging manual:

          2. Histologically verified adenocarcinoma of the colon.

          3. Signed informed consent.

        Exclusion Criteria:

          1. Pregnancy or lactation.

          2. The presence of synchronous or metachronous malignant tumors.

          3. Distant metastases to the liver, lungs, peritoneal carcinomatosis and other organs.

          4. Neoadjuvant chemotherapy.

          5. Suspected Lynch syndrome.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sergey Achkasov, professor</last_name>
    <phone>+74991999308</phone>
    <email>achkasovy@mail.ru</email>
  </overall_contact>
  <location>
    <facility>
      <name>State Scientific Centre of Coloproctology</name>
      <address>
        <city>Moscow</city>
        <zip>123423</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>May 30, 2018</study_first_submitted>
  <study_first_submitted_qc>June 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2018</study_first_posted>
  <last_update_submitted>September 4, 2019</last_update_submitted>
  <last_update_submitted_qc>September 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>State Scientific Centre of Coloproctology, Russian Federation</investigator_affiliation>
    <investigator_full_name>Achkasov Sergey</investigator_full_name>
    <investigator_title>Professor Sc.State Scientific Centre of Coloproctology, Head of Surgical department of sugery and oncology of colon, Moscow,Russian Federation</investigator_title>
  </responsible_party>
  <keyword>intraperitoneal chemotherapy</keyword>
  <keyword>Peritoneal Carcinomatosis</keyword>
  <keyword>Colonic Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

